Short answer
LifeStance Health Group, Inc. (LFST) filed its fiscal 2025 10-K annual report with the SEC on Feb 25, 2026. It reported revenue of $1.4B (+13.9% year over year) and net income of $10M.
- Top risk flagged: Regulatory risk from the No Surprises Act (effective Jan 1, 2022) causing payment disputes and penalties for billing and provider directory inaccuracies
FY2025 key financial metrics · XBRL
- Revenue
- $1.4B
- +13.9% YoY
- Net income
- $10M
- +116.8% YoY
- Operating margin
- 1.7%
- +4.2 pp YoY
- ROE
- 0.6%
- +4.6 pp YoY
- Operating cash flow
- $146M
- +36.3% YoY
Source: XBRL data from the LifeStance Health Group, Inc. (LFST) FY2025 10-K on SEC EDGAR. USD.
LifeStance Health Group, Inc. FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business: Nationwide outpatient mental healthcare platform employing 8,040 clinicians across 33 states with integrated virtual and in-person care
- Strategic shift: Prioritized virtual visits leading to significant reduction of physical office footprint and closure of underoccupied centers in 2023
- Quantitative metric: 1.0 million unique patients treated in 2025 through approximately 9.0 million visits, with 87% having two or more visits
- Emphasis on integrated care: Over 13 active integrated care programs partnering with primary care and specialists to unify mental and physical healthcare
- Noteworthy fact: 90% of revenue derived from commercial in-network payors, enhancing affordability and access through extensive payor contracts
Management Discussion & Analysis
- Cash and cash equivalents $248.6M in 2025 vs $154.6M in 2024; operating cash flow $146.2M in 2025 vs $107.3M in 2024
- Debt outstanding $282.8M in 2025 vs $290.0M in 2024 under 2024 Credit Agreement; compliance with leverage and interest coverage covenants
- Investing cash outflow $36.1M for property and equipment in 2025 vs $21.6M in 2024; financing activities used $16.0M in 2025 vs $9.9M in 2024 due to loan repayments and equity award settlements
- No explicit revenue or profit margins disclosed in excerpt; reported $9.7M net income in 2025 vs $57.4M net loss in 2024 mentioned in cash flow section
- Management expects existing cash sufficient for 12 months; growth, acquisitions, and market expansion are key risks requiring potential additional financing
Risk Factors
- Regulatory risk from the No Surprises Act (effective Jan 1, 2022) causing payment disputes and penalties for billing and provider directory inaccuracies
- Geopolitical/macroeconomic exposure from 29% revenue concentration with UnitedHealthcare (14%) and Elevance Health (15%), risking impact from reimbursement changes
- Operational vulnerability in clinician recruitment and retention amid rising labor costs and potential unionization increasing expenses and turnover
- Competitive threat from emerging AI and machine learning technologies reducing demand for licensed clinician care, impacting patient volumes
- Financial risk from high capital expenditures on new centers leading to margin pressure until patient visits generate revenue
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.